Myomo (MYO) Cost of Revenue (2016 - 2025)
Myomo (MYO) posted Cost of Revenue of $3.6 million for Q3 2025, up 1.34% on a QoQ basis from $3.6 million in Q2 2025, and up 61.29% year-over-year from $2.3 million in Q3 2024.
Myomo (MYO) Cost of Revenue (2016 - 2025) Analysis & Trends
Myomo's Cost of Revenue history runs 10 years deep, the most recent figure standing at $3.6 million for Q3 2025.
- Quarterly Cost of Revenue rose 61.29% year-over-year to $3.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $13.9 million (up 84.08% YoY) and the FY2024 annual result came in at $9.4 million, up 54.58% from the prior year.
- Cost of Revenue was $3.6 million for Q3 2025 at Myomo, up from $3.6 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $3.6 million in Q3 2025 and bottomed at $623152.0 in Q1 2021.
- A 5-year average of $1.8 million and a median of $1.5 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue fell 11.75% — and 2025, when it jumped 121.4%.
- Myomo's Cost of Revenue stood at $909175.0 in 2021, then surged by 55.52% to $1.4 million in 2022, then climbed by 16.8% to $1.7 million in 2023, then surged by 109.1% to $3.5 million in 2024, then gained by 5.65% to $3.6 million in 2025.
- Business Quant data shows MYO's Cost of Revenue at $3.6 million in Q3 2025, $3.6 million in Q2 2025, and $3.2 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.68 Mn |